Beware `False Moderates'

The article by Ron Kaufman on animal research in the May 25, 1992, issue of The Scientist (page 8) posited two extremes, and then led readers to a "middle" path. In the controversy over the use of animals in medical research, however, one of the opponents does not represent an extreme. On one side are the abolitionists, who believe that no matter how necessary to human health or painless to animals, the use of animals is unjustifiable. The true opposite would be people advocating the right to

Written bySandra Bressler
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article by Ron Kaufman on animal research in the May 25, 1992, issue of The Scientist (page 8) posited two extremes, and then led readers to a "middle" path. In the controversy over the use of animals in medical research, however, one of the opponents does not represent an extreme.

On one side are the abolitionists, who believe that no matter how necessary to human health or painless to animals, the use of animals is unjustifiable. The true opposite would be people advocating the right to do anything they want with animals. In this case, instead, we have research scientists, the vast majority of whom believe that strong regulation of animal use is appropriate, and that unnecessary pain is abhorrent, but that responsible, judicious use of animals is indispensable to medical progress. This is hardly a contest of extremes. Yet it allows false "moderates" (Martin Stephens of the Humane ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies